|
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. == References == 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ozoralizumab」の詳細全文を読む スポンサード リンク
|